Novavax, Inc.NVAXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-136.62%
↓ 322% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-32.36%
Historical baseline
PeriodValue
Q4 2025-136.62%
Q3 2025184.58%
Q2 202531.29%
Q1 2025-7.13%
Q4 2024-19.58%
Q3 2024-146.08%
Q2 2024476.12%
Q1 202452.74%
Q4 2023-345.80%
Q3 202376.94%
Q2 202347.19%
Q1 2023-176.36%
Q4 2022-204.37%
Q3 202277.35%
Q2 2022-93.09%
Q1 202274.15%
Q4 2021-140.89%
Q3 2021-198.43%
Q2 2021-78.22%
Q1 2021615.75%
Q4 2020-1878.88%
Q3 2020-105.62%
Q2 2020600.36%
Q1 20202.67%
Q4 201926.40%
Q3 2019-7.48%
Q2 201940.69%
Q1 2019-11.80%
Q4 2018-35.07%
Q3 201816.16%
Q2 201839.51%
Q1 2018-105.98%
Q4 201713.90%
Q3 2017-21.17%
Q2 201720.38%
Q1 201736.95%
Q4 20161.78%
Q3 2016-0.52%
Q2 201611.17%
Q1 2016-27.54%